Celera, Genentech ink deal to develop protein-based drugs

09/29/2004 | Washington Post (tiered subscription model), The

Celera Genomics Group and Genentech have signed an agreement to share possible therapeutic discoveries, with Genentech financing development of protein-based drugs produced by Celera for treating cancer. Celera has made two similar arrangements with other pharmaceutical or biotechnology companies.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ